A Case of a Laryngeal MALT Lymphoma in a Patient with a History of Gastric MALT

Table 1

Characteristics of the English-language reported cases of supraglottic laryngeal lymphomas from 1997 to 2014.

Study	Age at presentation	Gender	Symptoms at presentation	Treatment	Disease status	Follow-up (mo)
Zhao et al., 2012 [15]	35	F	Hoarseness	2 cycles CHOP, 27 Gy	NED	3
Markou et al., 2010 [18]	67	M	Hoarseness, stridor, dyspnea	Immediate tracheostomy, CHOP	NED	48
Gonzàlez et al., 2009 [19]	42	F	Cough, dysphonia	RT	NED	96
Arndt et al., 2007 [20]	34	F	Hoarseness	Doxycycline, FCR regimen	NED	6
Fujita et al., 2007 [21]	64	M	Hoarseness	CHOP-R	NED	18
Kania et al., 2005 [22]	46	M	Dysphonia	Co2 laser excision, Omeprazole, Amoxicillin, Clarithromycin	NED	24
Caletti et al., 2003 [17]	57	M	Hoarseness	Anti-H. pylori therapy	NED	46
Cheng et al., 1999 [23]	58	F	Hoarsness and foreign body sensation	30 Gy	NED	12
de Bree et al., 1998 [24]	36	F	Hoarseness	Debulking and 28 Gy	NED	24
Kato et al., 1997 [25]	54	F	Dysphonia	CHOP and RT, lung: surgery and RT	NED	35

CHOP: cyclophosphamide, hydroxydaunorubicin, vincristine, prednisone.
CHOP-R: cyclophosphamide, hydroxydaunorubicin, vincristine, prednisone, rituximab.
FCR: fludarabine, cyclophosphamide, rituximab.
NED: no evidence of disease.
SOB: shortness of breath.
mo: months.
RT: radiotherapy.
Gy: gray.